The House Resolution introduced by Representatives DelloSo, Waxman, Schlossberg, Venkata, Hill-Evans, Kazeem, Probst, Sanchez, and Neilson designates the week of May 4 through 10, 2025, as "Tardive Dyskinesia Awareness Week" in Pennsylvania. This initiative aims to raise awareness about tardive dyskinesia (TD), a movement disorder that can occur in individuals treated with dopamine receptor blocking agents (DRBAs) for serious mental health and gastrointestinal conditions. The resolution highlights the importance of recognizing the symptoms of TD, as it is estimated that around 800,000 people in the U.S. are affected, with a significant portion remaining undiagnosed.

The resolution emphasizes the need for regular monitoring and screenings for TD by healthcare providers, as recommended by the American Psychiatric Association. It also notes that clinical research has led to FDA-approved treatments for adults with TD, which can significantly improve the quality of life for those affected. By designating this week, the House of Representatives encourages both the public and the medical community to become more informed about tardive dyskinesia, ultimately aiming to enhance recognition and treatment of the disorder.